IBS study links gene variants to blood sugar and gut symptoms

NCT ID NCT07309601

Recruiting now Knowledge-focused Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 14 times

Summary

This study looks at people with Irritable Bowel Syndrome (IBS) who have gene variants that reduce their ability to digest starch and sugar. Researchers want to see if these individuals have a smaller rise in blood sugar after a meal and more bowel symptoms compared to those with normal digestion. About 70 participants will eat a sugary breakfast and have their blood sugar measured over two hours, while also reporting any symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBS (IRRITABLE BOWEL SYNDROME) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Skåne University Hospital
RECRUITING

Malmö, Skåne County, 20502, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

IBS (IRRITABLE BOWEL SYNDROME) IBS - IRRITABLE BOWEL SYNDROME SUCRASE ISOMALTASE DEFICIENCY